Cargando…
Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients
INTRODUCTION: Lung transplant recipients (LuTX) represent a vulnerable population for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Even though many vaccines are already developed, more clinical data need to support effective immunological response in immunocompromised patients. METH...
Autores principales: | Bárczi, Enikő, Varga, Viktória, Nagy, Alexandra, Eszes, Noémi, Jáky‐Kováts, Zsuzsanna, Müller, Veronika, Bohács, Anikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311263/ https://www.ncbi.nlm.nih.gov/pubmed/35894705 http://dx.doi.org/10.1002/iid3.646 |
Ejemplares similares
-
Peripheral blood and bronchoalveolar leukocyte profile in lung transplant recipients and their changes according to immunosuppressive regimen: A single‐center experience
por: Jáky‐Kováts, Zsuzsanna, et al.
Publicado: (2022) -
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
por: Barczi, Eniko, et al.
Publicado: (2020) -
Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox
por: Nagy, Alexandra, et al.
Publicado: (2022) -
Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline
por: Nagy, Alexandra, et al.
Publicado: (2021) -
Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry
por: Nagy, Tamas, et al.
Publicado: (2022)